Revelstoke Capital Partners
260 N. Josephine St.Denver, CO 80206
Website: revelstokecapital.com
Firm Size
- Assets Under Management (AUM):$6 Billion
- Number of Funds:21
- Employees:51
- Firm Type:Private Equity
- Focus Areas:
Software & Technology
Services
Healthcare
Description
Revelstoke Capital Partners is a private equity and venture capital firm based in Denver, Colorado. The firm focuses on making investments in the healthcare industry, particularly in companies operating in the healthcare services and healthcare technology sectors. Revelstoke seeks to partner with innovative and growing healthcare businesses with a goal of driving sustainable growth and enhancing value. With a team of experienced professionals and a proven track record, Revelstoke offers strategic guidance, operational expertise, and capital resources to its portfolio companies. The firm is dedicated to creating long-term partnerships and providing support to companies at all stages of their growth journey. Overall, Revelstoke Capital Partners strives to be a trusted and value-added partner in the healthcare sector.Latest News
Powered by
Feb 21, 2024: Revelstoke Capital Partners Announces Partner Promotions
Revelstoke Capital Partners ("Revelstoke"), a Denver -based private equity firm focused on building industry-leading companies in the healthcare and related health and wellness sectors, today announced four internal Partner promotions. These Partners play a critical role in leading Revelstoke's finance, value creation, ESG, and investor relations functions. Effective immediately:
Nov 03, 2023: Revelstoke Capital Partners Named to Inc.'s 2023 List of Founder-Friendly Investors
Revelstoke Capital Partners ("Revelstoke"), a healthcare-focused private equity firm with $5.6 billion of assets under management, is pleased to announce that it has been named to Inc.'s fifth annual Founder-Friendly Investors list, which honors the private equity, venture capital, and debt firms with the best track records of success backing entrepreneurs for the Firm's third consecutive year.
Oct 10, 2023: Revelstoke Capital Partners Announces Strategic Minority Investment From Bonaccord Capital Partners
Revelstoke Capital Partners ("Revelstoke" or the "Firm"), a healthcare-focused private equity firm with $5.6 billion of assets under management, is pleased to announce that Bonaccord Capital Partners ("Bonaccord" or "BCP") made a passive minority investment in the firm. Bonaccord, a subsidiary of P10, Inc. (NYSE: PX), is a private equity platform dedicated to acquiring non-control equity interests in leading private markets investment firms.
Aug 07, 2023: Revelstoke Capital Partners Raises Funds with $1.7 Billion of Committed Capital
Revelstoke Capital Partners ("Revelstoke"), a Denver -based private equity firm with $5.8 billion of assets under management, announced today that it has completed the successful fundraising for Revelstoke Capital Partners Fund III, L.P. ("RCP Fund III") and various affiliated investment vehicles totaling $1.7 billion . RCP Fund III substantially surpassed its target of $1 billion .
Aug 02, 2023: Empire Portfolio Group™ Signs Area Development & Franchise Agreements with Relive Health™
Empire Portfolio Group ("Empire"), a leading health and wellness services developer and operator, announced today the expansion of its brand portfolio through a new franchising agreement with Relive Franchising LLC ("Relive Health"), a Florida -based provider of anti-aging and wellness services. Empire is currently a successful area developer and franchisee of Orangetheory ® Fitness , the heart rate-based interval training fitness brand. This agreement broadens Empire's brand offerings and marks the first new brand addition since Empire partnered with Revelstoke Capital Partners ("Revelstoke"), a Denver -based private equity firm, in December 2020.